Vyzkoušejte nový nástroj s podporou AI
Summon Research Assistant
BETA
CCL17 and CCL22/CCR4 signaling is a strong candidate for novel targeted therapy against nasal natural killer/T-cell lymphoma
Kumai, Takumi, Nagato, Toshihiro, Kobayashi, Hiroya, Komabayashi, Yuki, Ueda, Seigo, Kishibe, Kan, Ohkuri, Takayuki, Takahara, Miki, Celis, Esteban, Harabuchi, Yasuaki
Published in Cancer Immunology, Immunotherapy (01.06.2015)
Published in Cancer Immunology, Immunotherapy (01.06.2015)
Get full text
Journal Article
Targeting HER-3 to elicit antitumor helper T cells against head and neck squamous cell carcinoma
Kumai, Takumi, Ohkuri, Takayuki, Nagato, Toshihiro, Matsuda, Yoshinari, Oikawa, Kensuke, Aoki, Naoko, Kimura, Shoji, Celis, Esteban, Harabuchi, Yasuaki, Kobayashi, Hiroya
Published in Scientific reports (05.11.2015)
Published in Scientific reports (05.11.2015)
Get full text
Journal Article